This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Volpara Health Technologies 将来の成長

Future 基準チェック /16

Volpara Health Technologies利益と収益がそれぞれ年間77.3%と17.4%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に-0.2% 77.8%なると予測されています。

主要情報

77.3%

収益成長率

77.8%

EPS成長率

Healthcare Services 収益成長	21.4%
収益成長率	17.4%
将来の株主資本利益率	-0.2%
アナリストカバレッジ	Low
最終更新日	03 May 2024

今後の成長に関する最新情報

Recent updates

What Volpara Health Technologies Limited's (ASX:VHT) 52% Share Price Gain Is Not Telling You

Dec 19

We're Hopeful That Volpara Health Technologies (ASX:VHT) Will Use Its Cash Wisely

Mar 06

Calculating The Intrinsic Value Of Volpara Health Technologies Limited (ASX:VHT)

Jun 03

Does Volpara Health Technologies (ASX:VHT) Have A Healthy Balance Sheet?

Mar 24

Volpara Health Technologies (ASX:VHT) Shareholders Booked A 93% Gain In The Last Three Years

Jan 28

Volpara Health Technologies (ASX:VHT) Is Using Debt Safely

Dec 24

Here's What We Think About Volpara Health Technologies' (ASX:VHT) CEO Pay

Nov 19

業績と収益の成長予測

ASX:VHT - アナリストの将来予測と過去の財務データ ( )NZD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2026	59	2	9	12	1
3/31/2025	56	-4	3	6	2
3/31/2024	47	-7	0	3	2
9/30/2023	38	-9	1	3	N/A
6/30/2023	36	-9	-3	0	N/A
3/31/2023	35	-10	-6	-4	N/A
12/31/2022	33	-12	-10	-8	N/A
9/30/2022	31	-13	-14	-12	N/A
6/30/2022	28	-15	-14	-12	N/A
3/31/2022	26	-16	-14	-11	N/A
12/31/2021	24	-17	-14	-12	N/A
9/30/2021	23	-17	-13	-12	N/A
6/30/2021	21	-17	-14	-13	N/A
3/31/2021	20	-17	-15	-14	N/A
12/31/2020	17	-19	-16	-15	N/A
9/30/2020	15	-21	-18	-17	N/A
6/30/2020	14	-21	-18	-17	N/A
3/31/2020	13	-20	-18	-17	N/A
12/31/2019	11	-18	-16	-15	N/A
9/30/2019	10	-15	-14	-13	N/A
6/30/2019	7	-13	-13	-12	N/A
3/31/2019	5	-12	-11	-11	N/A
12/31/2018	4	-11	-11	-10	N/A
9/30/2018	4	-10	-10	-10	N/A
6/30/2018	3	-9	-9	-9	N/A
3/31/2018	3	-9	-8	-8	N/A
12/31/2017	2	-9	-8	-8	N/A
9/30/2017	2	-9	-8	-8	N/A
6/30/2017	2	-9	N/A	-8	N/A
3/31/2017	2	-10	N/A	-8	N/A
12/31/2016	2	-34	N/A	N/A	N/A
9/30/2016	3	-33	N/A	-6	N/A
6/30/2016	3	-32	N/A	-5	N/A
3/31/2016	3	-30	N/A	-3	N/A
3/31/2015	2	-3	N/A	-2	N/A
3/31/2014	1	-3	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: VHT今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: VHT今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: VHT今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: VHTの収益 ( 17.4% ) Australian市場 ( 5.2% ) よりも速いペースで成長すると予測されています。

高い収益成長: VHTの収益 ( 17.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: VHT 3 年以内に赤字になると予測されています。

This company listing is no longer active

Volpara Health Technologies 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Price target decreased by 7.7% to AU$0.92

Price target decreased by 13% to AU$1.00

Price target increased by 14% to AU$1.15

Price target decreased by 16% to AU$1.01

Forecast breakeven date pushed back to 2026

Consensus EPS estimates fall by 137%, revenue upgraded

Recent updates

Volpara Health Technologies Limited Appoints Craig Hadfield Joins as Chief Financial Officer

Price target decreased by 7.7% to AU$0.92

Volpara Health Technologies Limited Launches MQSA Compliance Software at the Society for Breast Imaging Symposium

Price target decreased by 13% to AU$1.00

What Volpara Health Technologies Limited's (ASX:VHT) 52% Share Price Gain Is Not Telling You

Lunit Inc. (KOSDAQ:A328130) agreed to acquire Volpara Health Technologies Limited (ASX:VHT) from Harbour Asset Management Limited and others for AUD300 million.

Price target increased by 14% to AU$1.15

First half 2024 earnings released: NZ$0.017 loss per share (vs NZ$0.021 loss in 1H 2023)

Price target decreased by 16% to AU$1.01

Forecast breakeven date pushed back to 2026

New major risk - Revenue and earnings growth

Volpara Health Technologies Limited to Report Q2, 2024 Results on Oct 17, 2023

An Unknown buyer acquired 4% stake in Reveal DX fromVolpara Health Technologies Limited (ASX:VHT).

Volpara Health Technologies Limited, Annual General Meeting, Aug 17, 2023

Volpara Health Technologies Limited to Report Q1, 2024 Results on Jul 21, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 137%, revenue upgraded

We're Hopeful That Volpara Health Technologies (ASX:VHT) Will Use Its Cash Wisely

Volpara Health Technologies Limited Appoints Mark Bouw as Independent, Non-Executive Director

Forecast breakeven date pushed back to 2025

First half 2023 earnings released: NZ$0.02 loss per share (vs NZ$0.034 loss in 1H 2022)

Volpara Health Technologies Limited Provides Revenue Guidance for the Full Year 2023

Forecast breakeven date moved forward to 2024

Consensus estimates of losses per share improve by 14%

Forecast breakeven date moved forward to 2024

Volpara Health Technologies Limited Appoints Fred Struve as Joint Company Secretary

Forecast to breakeven in 2025

Volpara Health Technologies Limited Announces the Appointment of Teri Thomas as Managing Director

Volpara Health Launches Professional Services to Accelerate Success for High-Risk Cancer Programs

Forecast breakeven date pushed back to 2025

Key Executive recently bought AU$67k worth of stock

Now 23% undervalued after recent price drop

Price target decreased to AU$1.15

Forecast breakeven date pushed back to 2025

Forecast breakeven date pushed back to 2025

Volpara Health Announces Chief Executive Officer Changes

No longer forecast to breakeven

Price target decreased to AU$1.62

No longer forecast to breakeven

First half 2022 earnings: EPS and revenues exceed analyst expectations

No longer forecast to breakeven

Price target increased to AU$2.00

Non-Executive Director Monica Saini has left the company

Price target decreased to AU$1.74

Volpara Grows Patent Collection with Recently Granted European Protection of Image Quantification

Insider recently sold AU$122k worth of stock

Calculating The Intrinsic Value Of Volpara Health Technologies Limited (ASX:VHT)

Consensus EPS estimates fall to -NZ$0.046

Forecast breakeven pushed back to 2024

Full year 2021 earnings released: NZ$0.07 loss per share (vs NZ$0.097 loss in FY 2020)

Price target decreased to AU$1.84

Price target increased to AU$1.99

Does Volpara Health Technologies (ASX:VHT) Have A Healthy Balance Sheet?

Volpara Health Technologies Signs Highest Value Contract to Date Via CRA Health

New 90-day low: AU$1.30

Volpara Health Technologies Limited (ASX:VHT) acquired CRA Health Services, Inc. for $22 million.

Price target raised to AU$1.81

New 90-day high: AU$1.54

Volpara Health Technologies (ASX:VHT) Shareholders Booked A 93% Gain In The Last Three Years

Volpara Health Technologies Limited to Report Q3, 2021 Results on Jan 28, 2021

Volpara Health Technologies (ASX:VHT) Is Using Debt Safely

Volpara Health Technologies Advises Major Customer Contract It Renewed and Extended in Second Quarter of Fiscal 2021 Is with the US Radiology Group

First half 2021 earnings released: NZ$0.036 loss per share

Here's What We Think About Volpara Health Technologies' (ASX:VHT) CEO Pay

Volpara Health Technologies Announces the Launch of BreastED

New 90-day high: AU$1.47

New 90-day low: AU$1.27

Volpara Health Technologies Limited to Report Q1, 2021 Results on Jul 28, 2020